期刊文献+

多囊卵巢综合征不孕患者未成熟卵泡抽吸术的疗效分析 被引量:1

Clinical Efficacy of Treating Infertile Women with Polycystic Ovary Syndrome by Using Ultrasound-guided Immature Follicle Aspiration
原文传递
导出
摘要 目的:探讨对克罗米芬抵抗的多囊卵巢综合征(PCOS)不孕患者在超声引导下行小卵泡抽吸术(IMFA)的治疗效果。方法:将42例PCOS合并克罗米芬(CC)抵抗的不孕患者,随机分为A组:19例,穿刺前用CC或来曲唑(LE)联合少量hMG促排卵;B组:23例,穿刺前用少量hMG促排卵。在阴道B超引导下进行未成熟卵泡抽吸术(IMFA),观察穿刺前及穿刺后第2周期患者的卵巢基础窦卵泡数(AFC)、抗苗勒氏管激素(AMH)、血中游离睾酮指数(FAI)、黄体生成素与卵泡刺激素的比值(LH/FSH),以及术后并发症、3个月促排卵情况和妊娠率。结果:42例患者治疗时均没有发生卵巢过度刺激综合征(OHSS)。与治疗前比较,穿刺术后A、B组AFC显著减少,AMH、FAI和LH/FSH显著降低(P<0.01)。A、B组间比较,FAI、LH/FSH、排卵率和妊娠率无统计学差异(P>0.05)。A、B组共21例妊娠,妊娠率为50%。42例患者均没有发生出血、感染、OHSS。结论:IMFA治疗克罗米芬抵抗的PCOS不孕患者有较好的疗效,本方法安全、有效。 Objective: To investigate the clinical efficacy of treating infertile women with polycystic ovary syndrome (PCOS) by using ultrasound-guided immature follicle aspiration (IMFA). Methods: A total of 42 infertile women with PCOS and clomiphene (CC) resistance were randomly divided into two groups. Group A: 19 cases were induced ovulation with CC or letrozole (LE) combined with small amount of hMG before puncture. Group B: 23 cases were induced ovulation with a small amount of hMG before puncture. After IMFA, endocrine function, ovulation instance and pregnancy rate within 3 months were observed. Results: Ovary hyperstimulation syndrome did not occur in all cases. Compared with pre-treating, free androgen index (FAI) in blood, anti-Mtillerian hormone (AMH), ratio of luteinizing hormone (LH) and follicle stimulating hormone (FSH) were significantly lower (P〈0.01), and rates of ovulation and pregnancy were significantly improved after IMFA (P〈0.01). Conclusion: IMFA would have a good clinical efficacy for treating infertile women with PCOS, and would be safe.
出处 《生殖与避孕》 CAS CSCD 2012年第8期523-526,共4页 Reproduction and Contraception
关键词 多囊卵巢综合征(PCOS) 克罗米芬(CC)抵抗 未成熟卵泡 阴道超声下抽吸术 polycystic ovary syndrome (PCOS) clomiphene resistance immature follicle ultrasound-guided immature follicle aspiration
  • 相关文献

参考文献11

  • 1Tasoula T, Caroline O, Gerard SC. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol, 2004, 60 (1):1-17.
  • 2朱楣光,苏延华,张以文.多囊卵巢综合征,见:曹泽毅(主编).中华妇产科学.北京:人民卫生出版社.1999:2127-86.
  • 3Lunde O, Djcseland O, GrCttum P. Polycystic ovarian syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection. Hum Reprod, 2001, 16(7):1479-85.
  • 4Amer SA, Li TC, Cooke ID. Repeated laparoscopic ovarian diathermy is effective in women with anovulatory infer- tility due to polycystic ovary syndrome. Fertil Steril, 2003, 79(5):1211-5.
  • 5Ferraretti AP, Gianaroli L, Magli MC, et al. Transvaginal ovarian drilling: a new surgicall treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome. Fertil Steril, 2001, 76(4):812-6.
  • 6Fernandez H, Alby JD, Gervaise A, et al. Operative transvaginal hydrolaparoscopy for treatment of poly- cystic ovary syndrome: a new minimally invasive surgery. Fertil Steril, 2001, 75(3):607-11.
  • 7陈子江,李媛,赵力新,姜晶晶,唐蓉,盛燕,高芹,张中和.超声下未成熟卵泡抽吸术治疗多囊卵巢综合征不孕的临床研究[J].中华妇产科杂志,2005,40(5):295-298. 被引量:83
  • 8Ficicioglu C, Kutlu T, Baqlam E, et al. Early follicular anti- Mtillerian hormone as an indicator of ovarian reserve. Fertil Steril, 2006, 85(3):592-6.
  • 9江欢,朱伟杰.抗苗勒氏管激素在多囊卵巢综合征患者卵巢功能调节中的作用[J].生殖与避孕,2011,31(11):757-760. 被引量:15
  • 10Adams JM, Taylor AE, Crowley WF Jr, et al. Polycystic ovarian morphology with regular ovulatory cycles: in- sights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab, 2004, 89(9):4343-50.

二级参考文献29

  • 1Teixeira J, Maheswaran S, Donahoe PK. Mtillerian inhibiting substance: An instructive developmental hormone with di- agnostic and possible therapeutic applications. Endocr Rev, 2001, 22(5):657-74.
  • 2Weenen C, Laven JS, von Bergh AR, et al. Anti-Miillerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod, 2004, 10(2):77-83.
  • 3Nilsson E, Rogers N, Skinner MK. Actions of anti-Mtillerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction, 2007, 134(2):209-21.
  • 4Dumesic DA, Lesnick TG, Stassart JP, et al. InWafollicular anti- Mtillerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovu-latory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertiliza- tion and embryo transfer. Fertil Steril, 2009, 92(1):217-21.
  • 5Das M, Gillott DJ, Saridogan E, et al. Anti-MiJllerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycysfic ovary syndrome. Hum Reprod, 2008, 23(9): 2122-6,.
  • 6Kevenaar ME, Themmen AP, van Kerkwijk AJ, et al. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod, 2009, 24(1): 241-9.
  • 7Crisosto N, Sir-Petermann T, Greiner M, et al. Testosterone- induced dowrtregulation of anti-Mtillerian hormone expressionin granulosa cells from small bovine follicles. Endocrine, 2009, 36(2):339-45.
  • 8Chen M J, Yang WS, Chen CL, et al. The relationship between anti-Mtillerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod, 2008, 23(4):952-7.
  • 9Nardo LG, Yates AP, Roberts SA, et al. The relationships be- tween AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and with- out polycystic ovary syndrome. Hum Reprod, 2009, 24(11): 2917-23.
  • 10Falbo A, Rocca M, Russo T, et al. Serum and follicular anti- MiJllerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. J Ovarian Res, 2010, 3(1): 16-21.

共引文献99

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部